Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

This study has been terminated.
(Grant funding expired, poor patient enrollment)
Children's Research Institute
rEVO Biologics
Information provided by (Responsible Party):
Robert Niebler, Medical College of Wisconsin Identifier:
First received: June 17, 2010
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)